Livoa LogoLivoa
EBV
IFN
JAK
STAT
IRF
EBNA1
FGFR2
Bemarituzumab
PI3K
AKT
TSC1/2
mTOR
PIP2
PIP3
PTEN
PDK1
HER2
Trastuzumab
Trastuzumab deruxtecan
Zanidatamab
RAS
RAF
MEK1/2
ERK1/2
MET
Savolitinib
Rilotumumab
Transcriptional
regulations

MSI-H/dMMR
Nucleus
Wnt
LRP 5/6
DVL
GSK-3β
CK1α
Axin
APC
β-Catenin
TCF/LEF
DKK1
DKN-01
CLDN 18.2
CLDN 18.2
Tight junction
Zolbetuximab
Osemitamab
SOT102
Growth Proliferation Differentiation Survival Invasion Migration
PD-1
Nivolumab
Pembrolizumab
Dostarlimab-gxly
B7-H3
VISTA
SNS-01
T cell
⊥
⊥
⊥
⊥
⊥

diag

by shal

0
0 uses